Nuo Therapeutics, Inc. (AURX) SEC Filing 10-K Annual report for the fiscal year ending Monday, December 31, 2018

Document And Entity Information

Consolidated Balance Sheets

Consolidated Balance Sheets (Parentheticals)

Consolidated Statements Of Cash Flows

Consolidated Statements Of Operations

Consolidated Statements Of Stockholders' Equity (Deficit)

Note 1 - Description Of Business And Bankruptcy Proceedings

Note 1 - Description Of Business And Bankruptcy Proceedings (Details Textual)

Note 10 - Income Taxes

Note 10 - Income Taxes (Details Textual)

Note 10 - Income Taxes (Tables)

Note 10 - Income Taxes - Deferred Tax Assets And Liabilities (Details)

Note 10 - Income Taxes - Income Tax Expense (Benefit) (Details)

Note 10 - Income Taxes - Income Tax Rate Reconciliation (Details)

Note 11 - Fair Value Measurements

Note 11 - Fair Value Measurements (Details Textual)

Note 12 - Commitments And Contingencies

Note 12 - Commitments And Contingencies (Details Textual)

Note 12 - Commitments And Contingencies (Tables)

Note 12 - Commitments And Contingencies - Future Minimum Lease Payments (Details)

Note 13 - Subsequent Events

Note 13 - Subsequent Events (Details Textual)

Note 2 - Liquidity And Summary Of Significant Accounting Principles

Note 2 - Liquidity And Summary Of Significant Accounting Principles (Details Textual)

Note 2 - Liquidity And Summary Of Significant Accounting Principles (Tables)

Note 2 - Liquidity And Summary Of Significant Accounting Principles - Adoption Of Asu 2016-18 (Details)

Note 2 - Liquidity And Summary Of Significant Accounting Principles - Anti-Dilutive Securities Excluded From The Computation Of Diluted Earnings (Loss) Per Share (Details)

Note 2 - Liquidity And Summary Of Significant Accounting Principles - Earnings (Loss) Per Share (Details)

Note 2 - Liquidity And Summary Of Significant Accounting Principles - Summary Of Concentration Risk (Details)

Note 2 - Liquidity And Summary Of Significant Accounting Principles - Summary Stock Option Valuation Assumptions (Details)

Note 3 - Distribution, Licensing And Collaboration Arrangements

Note 3 - Distribution, Licensing And Collaboration Arrangements (Details Textual)

Note 4 - Receivables

Note 4 - Receivables (Details Textual)

Note 4 - Receivables (Tables)

Note 4 - Receivables - Accounts And Other Receivable, Net (Details)

Note 5 - Property And Equipment

Note 5 - Property And Equipment (Details Textual)

Note 5 - Property And Equipment (Tables)

Note 5 - Property And Equipment - Property And Equipment, Net (Details)

Note 6 - Goodwill And Other Intangible Assets

Note 6 - Goodwill And Other Intangible Assets (Details Textual)

Note 6 - Goodwill And Other Intangible Assets (Tables)

Note 6 - Goodwill And Other Intangible Assets - Changes In Goodwill (Details)

Note 6 - Goodwill And Other Intangible Assets - Intangible Assets (Details)

Note 7 - Accrued Liabilities

Note 7 - Accrued Liabilities (Tables)

Note 7 - Accrued Liabilities - Summary Of Accrued Liabilities (Details)

Note 8 - Convertible Notes And Stock Purchase Warrants

Note 8 - Convertible Notes And Stock Purchase Warrants (Details Textual)

Note 9 - Equity And Stock-Based Compensation

Note 9 - Equity And Stock-Based Compensation (Details Textual)

Note 9 - Equity And Stock-Based Compensation (Tables)

Note 9 - Equity And Stock-Based Compensation - Stock Option Activity (Details)

Note 9 - Equity And Stock-Based Compensation - Stock-Based Compensation Expense (Details)

Significant Accounting Policies (Policies)